Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank
Authors
Keywords
-
Journal
CIRCULATION
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-06-20
DOI
10.1161/circulationaha.119.041149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantifying Importance of Major Risk Factors for Coronary Heart Disease
- (2019) Michael J. Pencina et al. CIRCULATION
- UK Biobank, big data, and the consequences of non-representativeness
- (2019) Katherine M Keyes et al. LANCET
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
- (2018) Michel R. Langlois et al. CLINICAL CHEMISTRY
- Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practice
- (2018) Stella Trompet et al. CURRENT OPINION IN LIPIDOLOGY
- Validity of Cardiovascular Disease Event Ascertainment Using Linkage to UK Hospital Records
- (2017) Mika Kivimäki et al. EPIDEMIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank
- (2017) Donald M. Lyall et al. JAMA Cardiology
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. ATHEROSCLEROSIS
- An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB
- (2016) Allan D. Sniderman et al. Journal of Clinical Lipidology
- Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein CholesterolCLINICAL PERSPECTIVE
- (2015) Mohamed B. Elshazly et al. CIRCULATION
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
- (2015) Cathie Sudlow et al. PLOS MEDICINE
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. CIRCULATION
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
- (2013) Samia Mora et al. CIRCULATION
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- What makes UK Biobank special?
- (2012) Rory Collins LANCET
- Non–high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training
- (2011) Smita I. Negi et al. Journal of Clinical Lipidology
- Non–High-Density Lipoprotein Cholesterol Versus Apolipoprotein B in Cardiovascular Risk Stratification
- (2011) Vimal Ramjee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid parameters for measuring risk of cardiovascular disease
- (2011) Benoit J. Arsenault et al. Nature Reviews Cardiology
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
- (2010) Michael J. Pencina et al. STATISTICS IN MEDICINE
- Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
- (2009) J. H. Contois et al. CLINICAL CHEMISTRY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine
- (2008) P. Elliott et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients
- (2008) Christie M. Ballantyne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
- (2008) Matthew J McQueen et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started